BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15701721)

  • 1. The beta3 subunit of the integrin alphaIIbbeta3 regulates alphaIIb-mediated outside-in signaling.
    Liu J; Jackson CW; Gruppo RA; Jennings LK; Gartner TK
    Blood; 2005 Jun; 105(11):4345-52. PubMed ID: 15701721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin αIIb-mediated PI3K/Akt activation in platelets.
    Niu H; Chen X; Gruppo RA; Li D; Wang Y; Zhang L; Wang K; Chai W; Sun Y; Ding Z; Gartner TK; Liu J
    PLoS One; 2012; 7(10):e47356. PubMed ID: 23082158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calreticulin-independent regulation of the platelet integrin alphaIIbbeta3 by the KVGFFKR alphaIIb-cytoplasmic motif.
    Reilly D; Larkin D; Devocelle M; Fitzgerald DJ; Moran N
    Platelets; 2004 Feb; 15(1):43-54. PubMed ID: 14985176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of CIB1 to the αIIb tail of αIIbβ3 is required for FAK recruitment and activation in platelets.
    Naik MU; Naik TU; Summer R; Naik UP
    PLoS One; 2017; 12(5):e0176602. PubMed ID: 28542214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique interaction between alphaIIb and beta3 in the head region is essential for outside-in signaling-related functions of alphaIIbbeta3 integrin.
    Hauschner H; Landau M; Seligsohn U; Rosenberg N
    Blood; 2010 Jun; 115(22):4542-50. PubMed ID: 20308600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct domains of alphaIIbbeta3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an alphaIIbbeta3 interacting peptide.
    Derrick JM; Shattil SJ; Poncz M; Gruppo RA; Gartner TK
    Thromb Haemost; 2001 Sep; 86(3):894-901. PubMed ID: 11583324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First description of an IgM monoclonal antibody causing α
    Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
    J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb.
    Yin H; Litvinov RI; Vilaire G; Zhu H; Li W; Caputo GA; Moore DT; Lear JD; Weisel JW; Degrado WF; Bennett JS
    J Biol Chem; 2006 Dec; 281(48):36732-41. PubMed ID: 17032655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling.
    Phillips DR; Nannizzi-Alaimo L; Prasad KS
    Thromb Haemost; 2001 Jul; 86(1):246-58. PubMed ID: 11487013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Pro126His beta propeller mutation in integrin alphaIIb causes Glanzmann thrombasthenia by impairing progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.
    Shen WZ; Ding QL; Jin PP; Wang XF; Jiang YZ; Li SM; Wang HL
    Blood Cells Mol Dis; 2009; 42(1):44-50. PubMed ID: 18976939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
    Pillois X; Peters P; Segers K; Nurden AT
    Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.
    Honda S; Tomiyama Y; Shiraga M; Tadokoro S; Takamatsu J; Saito H; Kurata Y; Matsuzawa Y
    J Clin Invest; 1998 Sep; 102(6):1183-92. PubMed ID: 9739052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.
    Morel-Kopp MC; Melchior C; Chen P; Ammerlaan W; Lecompte T; Kaplan C; Kieffer N
    Thromb Haemost; 2001 Dec; 86(6):1425-34. PubMed ID: 11776310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3.
    Trumel C; Plantavid M; Lévy-Tolédano S; Ragab A; Caen JP; Aguado E; Malissen B; Payrastre B
    J Thromb Haemost; 2003 Feb; 1(2):320-9. PubMed ID: 12871507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylated peptide, being derived from the carboxyl-terminal sequence of the integrin αIIb cytoplasmic domain, inhibits talin binding to αIIbβ₃.
    Gkourogianni A; Egot M; Koloka V; Moussis V; Tsikaris V; Panou-Pomonis E; Sakarellos-Daitsiotis M; Bachelot-Loza C; Tsoukatos DC
    Platelets; 2014; 25(8):619-27. PubMed ID: 24246298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin alphaIIb-subunit cytoplasmic domain mutations demonstrate a requirement for tyrosine phosphorylation of beta3-subunits in actin cytoskeletal organization.
    Yamodo IH; Blystone SD
    Cell Commun Adhes; 2004; 11(5-6):121-35. PubMed ID: 16194880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3.
    Basani RB; French DL; Vilaire G; Brown DL; Chen F; Coller BS; Derrick JM; Gartner TK; Bennett JS; Poncz M
    Blood; 2000 Jan; 95(1):180-8. PubMed ID: 10607701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors.
    González-Manchón C; Butta N; Larrucea S; Arias-Salgado EG; Alonso S; López A; Parrilla R
    Thromb Haemost; 2004 Dec; 92(6):1377-86. PubMed ID: 15583747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
    Tomiyama Y; Shiraga M; Kinoshita S; Ambo H; Kurata Y; Matsuzawa Y; Kunicki TJ
    Thromb Haemost; 1998 Nov; 80(5):735-42. PubMed ID: 9843164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.